- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
Patent holdings for IPC class C07K 16/18
Total number of patents in this class: 12125
10-year publication summary
|
810
|
863
|
832
|
874
|
787
|
793
|
717
|
736
|
706
|
197
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1120 |
219 |
| Alexion Pharmaceuticals, Inc. | 644 |
187 |
| Genentech, Inc. | 4052 |
170 |
| Ablynx N.V. | 408 |
147 |
| The Regents of the University of California | 20473 |
141 |
| Regeneron Pharmaceuticals, Inc. | 4570 |
126 |
| Amgen Inc. | 4327 |
123 |
| Chugai Seiyaku Kabushiki Kaisha | 1390 |
106 |
| Eli Lilly and Company | 4018 |
106 |
| F. Hoffmann-La Roche AG | 7832 |
104 |
| Prothena Biosciences Limited | 190 |
102 |
| AC Immune S.A. | 273 |
95 |
| H. Lundbeck A/S | 1244 |
95 |
| Hoffmann-La Roche Inc. | 3665 |
94 |
| Sanofi | 4195 |
81 |
| The Trustees of the University of Pennsylvania | 4392 |
76 |
| Novartis AG | 10376 |
75 |
| The Johns Hopkins University | 5796 |
60 |
| Bristol-myers Squibb Company | 4814 |
58 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2956 |
58 |
| Other owners | 9902 |